Skip to main content

Table 2 Comparison of clinical parameters after methimazole treatment in patients with overt hyperthyroidism

From: Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism

Parameters

Clinical hyperthyroidism group (n = 39)

Baseline

After treatment

Age, y

40.31 ± 11.45

40.31 ± 11.45

Gender, M/F, n

15/24

15/24

Weight (kg)

54.60 ± 6.72

56.83 ± 6.38**

BMI, kg/m2

20.67 ± 2.75

21.90 ± 2.54

SBP (mmHg)

120 ± 9

118 ± 10

DBP (mmHg)

76 ± 7

74 ± 7

TC (mM)

3.63 ± 0.83

3.82 ± 0.76**

TG (mM)

1.10 ± 0.37

1.15 ± 0.34

LDLC (mM)

1.51 ± 0.46

1.81 ± 0.51**

HDLC (mM)

1.48 ± 0.42

1.49 ± 0.35

ALT (IU/L)

31 ± 21

32 ± 15

AST (IU/L)

30 ± 11

31 ± 12

FT3 (pmol/L)

14.68 ± 6.39

9.40 ± 4.59**

FT4 (pmol/L)£

34.12 (27.61,48.93)

25.69 (21.05,30.68)**

TSH (pmol/L)£

0.006 (0.004,0.010)

0.180 (0.094,0.400)**

ZAG (mg/L)

64.85 ± 12.84

55.72 ± 8.83**